Last update 23 Jan 2025

IL-7Rα x TGF-β x TGFBR2

Basic Info

Related Targets
IL-7RαTGF-βTGFBR2

Related

1
Drugs associated with IL-7Rα x TGF-β x TGFBR2
WO2023051735
Patent Mining
Target
IL-7Rα x TGF-β x TGFBR2
Mechanism-
Active Org.
Gracell Biotechnologies (Shanghai) Co., Ltd.Gracell Biotechnologies (Shanghai) Co., Ltd.
Originator Org.
Gracell Biotechnologies (Shanghai) Co., Ltd.Gracell Biotechnologies (Shanghai) Co., Ltd.
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with IL-7Rα x TGF-β x TGFBR2
Login to view more data
100 Translational Medicine associated with IL-7Rα x TGF-β x TGFBR2
Login to view more data
0 Patents (Medical) associated with IL-7Rα x TGF-β x TGFBR2
Login to view more data
1
Literatures (Medical) associated with IL-7Rα x TGF-β x TGFBR2
01 Mar 2010AIDS Research and Human RetrovirusesQ4 · MEDICINE
HIV-Specific TGF-β-Positive CD4+T Cells Do Not Express Regulatory Surface Markers and Are Regulated by CTLA-4
Q4 · MEDICINE

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free